Results
|
5621.
|
|
|
5622.
|
|
|
5623.
|
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study]. [electronic resource] by
- Reinhardt, D
- Langebrake, C
- Creutzig, U
- Vormoor, J
- Brune, C
- Thorwesten, M
- Ingiliz, P
- Hrusak, O
- Dworzak, M
- Griesinger, F
Producer: 20021204
In:
Klinische Padiatrie vol. 214
Availability: No items available.
|
|
5624.
|
|
|
5625.
|
|
|
5626.
|
|
|
5627.
|
|
|
5628.
|
|
|
5629.
|
|
|
5630.
|
|
|
5631.
|
[A case of small-cell lung cancer effectively treated by bi-weekly administration of amrubicin]. [electronic resource] by
- Kurai, Jun
- Igishi, Tadashi
- Suyama, Hisashi
- Kodani, Masahiro
- Fukuoka, Yasushi
- Miyata, Masanori
- Touge, Hirokazu
- Hasegawa, Yasuaki
- Yasuda, Kazuto
- Hitsuda, Yutaka
- Shimizu, Eiji
Producer: 20060403
In:
Gan to kagaku ryoho. Cancer & chemotherapy vol. 33
Availability: No items available.
|
|
5632.
|
|
|
5633.
|
|
|
5634.
|
|
|
5635.
|
|
|
5636.
|
|
|
5637.
|
|
|
5638.
|
Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. [electronic resource] by
- Xenidis, N
- Kotsakis, A
- Kalykaki, A
- Christophyllakis, Ch
- Giassas, S
- Kentepozidis, N
- Polyzos, A
- Chelis, L
- Vardakis, N
- Vamvakas, L
- Georgoulias, V
- Kakolyris, S
Producer: 20100921
In:
Lung cancer (Amsterdam, Netherlands) vol. 68
Availability: No items available.
|
|
5639.
|
Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study. [electronic resource] by
- Dimitroulis, John
- Rapti, Angeliki
- Stathopoulos, George P
- Rigatos, Sotiris
- Stathopoulos, John
- Koutantos, John
- Athanasiadis, Athanasios
- Tsikritsaki, Kyriaki
- Karaindros, Dimitris
- Katis, Kostas
- Antoniou, Dimosthenis
- Toumbis, Michalis
- Giamboudakis, Pantelis
Producer: 20081104
In:
Oncology reports vol. 20
Availability: No items available.
|
|
5640.
|
|